Aduhelm, the new drug to beat Alzheimers or the bomb that blows the Amyloid-B Hypothesis out of the water once and for all?
It failed its clinical trials but Aduhelm, the drug that dissolves plaques on the brain, has been approved by the FDA for the Accelerated Approval Lane amidst doubts about its efficacy or safety.
February 6, 2022
